JSM 2004 - Toronto

JSM Activity #339

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page
Legend: = Applied Session, = Theme Session, = Presenter
FRY = Fairmont Royal York, ICH = InterContinental Hotel, TCC = Metro Toronto Convention Center
Add To My Program
339 Wed, 8/11/04, 10:30 AM - 12:20 PM TCC-701 B
Clinical Trials - Contributed - Papers
Biopharmaceutical Section
Chair(s): Donghui Zhang, Merck & Co., Inc.
     10:35 AM   Proportion of Similar Response to Evaluate Similarity of Immune Response in Vaccines Clinical Trials — Katherine E.D. Giacoletti, Merck & Co., Inc.; Joseph F. Heyse, Merck & Co., Inc.
     10:50 AM   A Comparison of Methods for the Joint Evaluation of Incidence and Severity — Xiaoming Li, Merck & Co., Inc.; Devan V. Mehrotra, Merck & Co., Inc.
     11:05 AM   Phase I Trial Statistical Assessment of the Tetrameric Single-chain Anti-CD20 — Kuang-Ho Chen, University of Alabama, Birmingham
     11:20 AM   On the Adaptiveness of a Simple Bayesian Model for Treatment Assignments in Clinical Trials — Abdul J. Sankoh, Aventis Pharmaceuticals
     11:35 AM   Comparison of One-way and Two-way Analysis of Variance for Center-stratified Sparse Data — Roger Qu, Forest Laboratories, Inc.; Bin Cheng, University of Wisconsin, Madison; Zhen R. Luo, Forest Laboratories, Inc.
     11:50 AM   Analysis of Clinical Data with Varying Time Intervals — Cong Chen, Merck & Co., Inc.
     12:05 PM   The Importance of Balance on Covariates in Clinical Trials: When Covariate-adjusted Analyses are Not Enough — Brenda L. Gaydos, Eli Lilly and Company
 

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004